
The Regulatory Review
@theregreview
Your daily source for regulatory news, analysis & commentary. From the Penn Program on Regulation at @Penn. RTs & links ≠ endorsements.
ID: 254363245
http://www.TheRegReview.org 19-02-2011 04:00:16
49,49K Tweet
5,5K Followers
2,2K Following

In a recent article, Daniel G. Aaron, MD, JD of @SJQuinney argues that corporate "capture" has hollowed out the U.S. Food and Drug Administration (FDA) premarket review process and urges Congress to pass the Premarket Review Restoration Act to restore rigorous, independent oversight.
